Key facts
- Arbital Health’s last known valuation is $107.0M (Jul 2025).
- It has raised $46.2M across 1 recorded rounds; the latest was Early Stage VC ($15.2M) in Dec 2023.
- Notable investors include Flex Capital, Transformation Capital, Healthy Ventures, Octave (San Francisco), Shaper Capital — 7 tracked in total.
- Arbital Health has filed 2 Form Ds with the SEC since 2023, most recently Aug 2024 ($15.2M sold to 22 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Arbital Health
Funding rounds
1 roundsAbout Arbital Health
Developer of a healthcare software platform designed for value-based care contract design, measurement, and adjudication. The company's platform facilitates and accelerates the transition towards value-based care, where providers are rewarded for positive patient outcomes, and creates the infrastructure layer, enabling clients with better value-based care contracting between providers, payers, enablers, employers, and life sciences companies.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 48
- Website
- arbitalhealth.com/
- Ownership
- Privately Held (backing)
Arbital Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arbital Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arbital Health in its N-PORT filings yet. We sweep new filings monthly.